Back

Clinical MRD Patient Cases

This page is designed to enable clinicians to access and share de-identified summaries of real patient cases for which minimal residual disease (MRD) testing has been utilized in clinical practice. These cases have been collected from current clonoSEQ users to illustrate the ways in which clonoSEQ MRD testing is being incorporated in the day-to-day management of chronic lymphocytic leukemia (CLL), multiple myeloma, and acute lymphoblastic leukemia (B-ALL) patients.

Scroll down to review the case library, or use the filters below to search for a case with specific characteristics. To inquire about submitting a patient case of your own, email casestudies@adaptivebiotech.com.

* This patient case includes examples of clonoSEQ MRD testing in blood. Blood-based MRD testing for patients with acute lymphoblastic leukemia is available as a CLIA-validated laboratory developed test (LDT) provided by Adaptive Biotechnologies. This use of clonoSEQ has not been approved or cleared by the FDA.

Submit a Case Study

Do you have a case study in which MRD results were used to inform care decisions? To inquire about submitting a patient case of your own, email casestudies@adaptivebiotech.com.